Bank of Montreal’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-16,163
| Closed | -$284K | – | 3678 |
|
|
2022
Q1 | $284K | Sell |
16,163
-15,433
| -49% | -$271K | ﹤0.01% | 2766 |
|
|
2021
Q4 | $622K | Buy |
31,596
+1,112
| +4% | +$21.9K | ﹤0.01% | 2177 |
|
|
2021
Q3 | $648K | Buy |
+30,484
| New | +$648K | ﹤0.01% | 2558 |
|
|
2020
Q4 | – | Sell |
-44,041
| Closed | -$792K | – | 4470 |
|
|
2020
Q3 | $792K | Buy |
+44,041
| New | +$792K | ﹤0.01% | 1780 |
|
|
2020
Q2 | – | Sell |
-46,388
| Closed | -$681K | – | 4294 |
|
|
2020
Q1 | $681K | Buy |
46,388
+2,522
| +6% | +$37K | ﹤0.01% | 1655 |
|
|
2019
Q4 | $765K | Sell |
43,866
-5,799
| -12% | -$101K | ﹤0.01% | 2034 |
|
|
2019
Q3 | $750K | Buy |
49,665
+15,670
| +46% | +$237K | ﹤0.01% | 1842 |
|
|
2019
Q2 | $573K | Buy |
33,995
+7,442
| +28% | +$125K | ﹤0.01% | 1970 |
|
|
2019
Q1 | $455K | Buy |
26,553
+24,072
| +970% | +$412K | ﹤0.01% | 2025 |
|
|
2018
Q4 | $37K | Sell |
2,481
-11,291
| -82% | -$168K | ﹤0.01% | 3069 |
|
|
2018
Q3 | $281K | Buy |
+13,772
| New | +$281K | ﹤0.01% | 2315 |
|
|
2015
Q3 | – | Sell |
-2,700
| Closed | -$76K | – | 3779 |
|
|
2015
Q2 | $76K | Buy |
+2,700
| New | +$76K | ﹤0.01% | 2650 |
|